PDS Biotechnology Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 42.94 million compared to USD 40.85 million a year ago. Basic loss per share from continuing operations was USD 1.39 compared to USD 1.43 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 USD | +1.38% | -0.17% | -40.54% |
May. 15 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.54% | 106M | |
+18.26% | 123B | |
+15.11% | 107B | |
-4.12% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.03% | 16.23B | |
+2.79% | 13.43B | |
+26.72% | 11.32B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- PDS Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023